Richard Proehl becomes vp of manufacturing at CML

Has spent more than 30 years in API manufacturing

Cambridge Major Laboratories (CML), a US producer of pharmaceutical intermediates and APIs, has welcomed Richard Proehl as vice president of manufacturing.

Proehl will be responsible for all plant scale manufacturing operations within the organisation, as well as all engineering and EHS functions. He brings more than 30 years of API manufacturing experience to the firm, based in Germantown, WI and has a strong focus on EHS and Quality Compliance.

‘Rick brings a wealth of experience to our team and his focus on quality and execution is a great fit with our company values,’ said Brian Scanlan, president and ceo of CML.

Prior to joining CML, Proehl was the St Louis site director for Covidien, where he was responsible for the company's largest API plant of about 900 employees.

‘The company's growth has been impressive and I will drive operational discipline in our manufacturing systems as we build on our strong fundamental capabilities and provide our customers with world class API manufacturing operations,’ said Proehl.

You may also like

Manufacturing

Cambridge Major Labs supports Summit antibiotic project

The chemistry outsourcing partner will help develop Summit’s antibiotic for Clostridium difficile
Manufacturing

API launch from new Cambridge Major Laboratories facility

This is the first commercial launch of an active pharmaceutical ingredient from its newest facility
Ingredients

AAIPharma Charleston sterile manufacturing receives MHRA approval

<p>International pharmaceutical services provider AAIPharma's sterile manufacturing plant in Charleston, South Carolina, US, has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to produce aseptic and lyophilised products.</p>
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Ingredients

Pangea Pharmaceuticals launches FDA-approved amlodipine oral solution Sdamlo

Pangea’s Sdamlo, the first FDA-approved amlodipine powder for oral solution, leverages a patent-pending lyophilisation process to enable precise unit-dose delivery and improved administration for paediatric, geriatric and dysphagic patients
Ingredients

Oncodesign Services extends GIP ARRONAX collaboration to secure astatine-211 supply

The company has extended its collaboration with the French radionuclide specialist to secure access to astatine-211, an alpha-emitting radioisotope of growing interest in targeted radiotherapy but constrained by its seven-hour half-life and limited production capacity
Ingredients

Evaporation and lyophilization for converting RP-HPLC peptide fractions into stable powders

A method to obtain research peptides in a stable, dry, and contamination-free form for long-term storage
Subscribe now